Public funding for mitochondrial donation: An Australian public deliberation
Should the current Australian MD research trial enable clinical provision, assuming that our participants' views are consistent with those of most Australians when informed of the trade-offs, benefits and costs, then it is likely that there will be strong public support for governments to fund access. However, some people may object to this expenditure.
Authors
- Ezra Kneebone (ORCID: https://orcid.org/0000-0002-1240-1739)
- Chris Degeling (ORCID: https://orcid.org/0000-0003-4279-3443)
- Megan Munsie (ORCID: https://orcid.org/0000-0003-3588-8321)
- Karinne Ludlow (ORCID: https://orcid.org/0000-0002-3179-1349)
- Jane Williams (ORCID: https://orcid.org/0000-0002-0142-0299)
- David R. Thorburn (ORCID: https://orcid.org/0000-0002-7725-9470)
- A. Jean Hill
- Giuliana Fuscaldo (ORCID: https://orcid.org/0000-0003-1451-4435)
- Liz Sutton
- Paul Scuffham (ORCID: https://orcid.org/0000-0001-5931-642X)
- Sarah Norris (ORCID: https://orcid.org/0000-0002-4733-6906)
- Ainsley J. Newson (ORCID: https://orcid.org/0000-0002-3460-772X)
- Catherine Mills
Institutions
- University of Technology Sydney (AU)
- Griffith University (AU)
- The University of Sydney (AU)
- The University of Melbourne (AU)
- University of Wollongong (AU)
- Victorian Clinical Genetics Services (AU)
- Migration Institute of Australia (AU)
- Sydney Local Health District (AU)
- Murdoch Children's Research Institute (AU)
- Monash University (AU)
Publication Details
- Journal
- BMC Medical Ethics
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1186/s12910-025-01284-4
- Citations
- 1
- Primary Topic
- Organ Donation and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Australian Government
- Novo Nordisk
- Novo Nordisk Fonden
- National Health and Medical Research Council